Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways

Christian Grant1, Unsong Oh, Kazunori Fugo

  • 1Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

Plos Pathogens
|May 3, 2006
PubMed

Insights

Forkhead box P3 (Foxp3) suppresses immune responses by inhibiting nuclear factor-kappaB (NF-kappaB) and cAMP-responsive element binding protein (CREB) pathways. High Foxp3 expression correlates with lower retroviral load and reduced disease severity in HTLV-I infections.

Area of Science:

  • Immunology
  • Molecular Biology
  • Virology

Background:

  • Forkhead box (Fox)/winged-helix transcription factors, including Foxp3, are crucial regulators of immune responses.
  • Foxp3 is a key marker for regulatory T cells, which play a vital role in immune suppression.
  • Retroviral infections like HIV-1 and HTLV-I pose significant health challenges, and understanding their pathogenesis is critical.

Purpose of the Study:

  • To investigate the downstream signaling pathways regulated by Foxp3.
  • To determine the impact of Foxp3 on the activation of nuclear factor-kappaB (NF-kappaB).
  • To explore Foxp3's role in the pathogenesis of human retroviral infections, specifically HIV-1 and HTLV-I.

Main Methods:

  • Overexpression of Foxp3 in HEK 293T cells and primary CD4+ T cells.
  • Deletion of the forkhead (FKH) domain to assess its role in Foxp3 function.
  • Analysis of NF-kappaB activation and transcription of retroviral promoters (HIV-1, HTLV-I).
  • Investigation of the cAMP-responsive element binding protein (CREB) pathway.
  • Correlation of Foxp3+CD4+CD25+ T cell percentages with HTLV-I proviral load in infected individuals.

Main Results:

  • Foxp3 overexpression led to a dose- and time-dependent decrease in NF-kappaB activation.
  • The FKH domain of Foxp3 was essential for suppressing NF-kappaB activity in HEK 293T cells.
  • Foxp3 suppressed transcription of HIV-1 and HTLV-I promoters via both NF-kappaB-dependent and -independent pathways.
  • The CREB pathway was identified as a target of Foxp3's suppressive activity.
  • Higher Foxp3 expression was associated with lower HTLV-I proviral load and absence of associated disease.

Conclusions:

  • Foxp3 plays a significant role in negatively regulating NF-kappaB and CREB signaling pathways.
  • Foxp3 can inhibit the transcription of human retroviral promoters, suggesting a role in controlling viral replication.
  • These findings indicate an expanded role for Foxp3 in regulating cellular and viral gene expression, with implications for retroviral pathogenesis and disease progression.

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...